GSK_Annual_Report_2021

Financial Statements GlaxoSmithKline Pharmaceuticals Limited 94 ( ` in lakhs) Notes As at March 31, 2021 As at March 31, 2020 ASSETS Non-current assets Property, plant and equipment 3 309,64.55 667,62.95 Right of use Assets 46 31,26.43 39,33.57 Capital work-in-progress 3 13,21.43 120,12.15 Investment property 4 1,32.87 1,47.25 Intangible assets 5 43,36.40 49,62.51 Financial assets (i) Investments 6 24,49.31 24,49.31 (ii) Deposits 7 8,06.08 8,21.56 (iii) Other financial assets 8 4,01.47 4,13.53 Current tax assets (net) 341,52.93 304,86.90 Deferred tax assets (net) 45 101,66.93 108,84.73 Other non-current assets 9 45,88.02 45,99.82 924,46.42 1374,74.28 Current assets Inventories 10 523,33.85 483,03.22 Financial assets (i) Trade receivables 11 215,60.46 99,80.12 (ii) Cash and cash equivalents 12 404,90.20 98,02.79 (iii) Bank balances other than (ii) above 13 752,77.48 968,37.73 (iv) Other financial assets 14 19,20.27 30,91.22 Other current assets 15 75,38.46 76,51.75 1991,20.72 1756,66.83 Assets classified as held for sale 16 180,11.84 11.23 2171,32.56 1756,78.06 TOTAL ASSETS 3095,78.98 3131,52.34 EQUITY AND LIABILITIES EQUITY Equity share capital 17 169,40.60 169,40.60 Other equity 18 1348,52.88 1670,63.37 Total equity 1517,93.48 1840,03.97 LIABILITIES Non-current liabilities Financial liabilities (i) Borrowings 19 - 2.40 (ii) Other financial liabilities 20 2,04.46 2,05.97 (iii) Other financial lease liabilities 20 20,24.99 26,83.72 Provisions 21 & 26 258,24.55 260,49.12 280,54.00 289,41.21 Current liabilities Financial liabilities (i) Trade payables Total outstanding dues of micro enterprises and small enterprises 22 5,26.94 5,21.38 Total outstanding dues of creditors other than micro enterprises and small enterprises 22 441,05.92 348,97.29 (ii) Other financial liabilities 23 171,90.23 142,89.62 (iii) Other financial lease liabilities 23 14,35.27 14,82.58 Other current liabilities 24 246,83.26 48,12.08 Provisions 25 & 26 254,17.62 280,66.59 Current tax liabilities (net) 163,72.26 161,37.62 1297,31.50 1002,07.16 Total liabilities 1577,85.50 1291,48.37 TOTAL EQUITY AND LIABILITIES 3095,78.98 3131,52.34 Standalone Balance Sheet as at March 31, 2021 The accompanying notes 1 to 56 are an integral part of the Standalone Financial Statements In terms of our report attached For Deloitte Haskins & Sells LLP For and on behalf of the Board of Directors Chartered Accountants R. S. Karnad Chairperson DIN: 00008064 S. Venkatesh Managing Director DIN: 07263117 Rupen K. Bhatt P. Thakur CFO & Whole-time Director DIN: 07971789 Partner D. Sundaram Audit Committee Chairman DIN: 00016304 A. Nadkarni Company Secretary FCS 10460 Mumbai, May 18, 2021 Mumbai, May 18, 2021